Showing results (1-10 of 8) with videos related to
Sort By:
Pageof 1
Stem Cells International|January 15, 2013
Parkinson's Disease in a Dish: What Patient Specific-Reprogrammed Somatic Cells Can Tell Us about Parkinson's Disease, If Anything?J Drouin-Ouellet, R A BarkerJournal of Internal Medicine|August 20, 2016
Brain repair and reprogramming: the route to clinical translationS Grealish, J Drouin-Ouellet, M ParmarBrain, Behavior, and Immunity|March 10, 2012
MyD88 deficiency results in both cognitive and motor impairments in miceJ Drouin-Ouellet, M LeBel, M Filali, et al.Brain, Behavior, and Immunity|March 8, 2011
The critical role of the MyD88-dependent pathway in non-CNS MPTP-mediated toxicityM Côté, J Drouin-Ouellet, F Cicchetti, et al.Biomaterials|November 21, 2020
Treating brain diseases using systemic parenterally-administered protein therapeutics: Dysfunction of the brain barriers and potential strategiesA Zaghmi, J Drouin-Ouellet, D Brambilla, et al.Journal of Immunology Research|March 5, 2025
Chemically Induced Senescence Prompts Functional Changes in Human Microglia-Like CellsS Armanville, C Tocco, Z Haj Mohamad, et al.Cell Death & Disease|April 29, 2016
GSK-3β-induced Tau pathology drives hippocampal neuronal cell death in Huntington's disease: involvement of astrocyte-neuron interactionsF L'Episcopo, J Drouin-Ouellet, C Tirolo, et al.Neurobiology of Disease|August 2, 2015
Cystamine/cysteamine rescues the dopaminergic system and shows neurorestorative properties in an animal model of Parkinson's diseaseG Cisbani, J Drouin-Ouellet, C Gibrat, et al.Pageof 1